- KANT Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
-
8-K Filing Data
Kineta (KANT) 8-K17 Jun 22Kineta Presents New Preclinical Data and Phase 1/2 Clinical Trial Design of KVA12.1 at the Tumor Myeloid-Directed Therapies SummitFinancial data
Company Profile